Isabel Aznarez

Fondateur chez STOKE THERAPEUTICS, INC.

54 ans

Consumer Services

Commercial Services

Health Technology

Profil

Dr. Isabel Aznarez is a Chief Technology Officer at Stoke Therapeutics, Inc. She is on the Board of Directors at Oligonucleotide Therapeutics Society, Inc. She received her undergraduate degree from Universidad De La Republica Uruguay and a doctorate degree from the University of Toronto.

Postes actifs de Isabel Aznarez

Sociétés	Poste	Début
STOKE THERAPEUTICS, INC.	Fondateur	01/06/2014
Oligonucleotide Therapeutics Society, Inc. Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics	Directeur/Membre du Conseil	01/01/2019

Tous les postes actifs de Isabel Aznarez

Formation de Isabel Aznarez

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Isabel Aznarez

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oligonucleotide Therapeutics Society, Inc. Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics	Commercial Services
Universidad De La Republica Uruguay Universidad De La Republica Uruguay Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases	Health Technology